The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Reddick Andrew D since year 2005.
The trader's CIK number is 1260882.
At the time of this reporting, Reddick Andrew D is the President and CEO of Acura Pharmaceuticals, Inc .
(stock ticker symbol ACUR.OB).
See this page for all insider trading activities at Acura Pharmaceuticals, Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2011-04-04||ACUR||Acura Pharmaceuticals, Inc||Option Ex||112,500||1.30||146,250|
|2009-11-24||ACUR||Acura Pharmaceuticals, Inc||Option Ex||425,000||1.30||552,500|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reddick Andrew D (President and CEO of Acura Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.